Journal article

CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB VERSUS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF THE PHASE 3 CANDOR STUDY BY NUMBER OF PRIOR LINES OFTHERAPY AND PRIOR THERAPIES

H Quach, A Nooka, O Samoylova, CP Venner, T Facon, A Spencer, SZ Usmani, K Weisel, M Mateos, K Kim, S Grosicki, K Suzuki, S Delimpasi, M Obreja, A Zahlten-Kumeli

Hematology Transfusion and Cell Therapy | Elsevier BV | Published : 2020

University of Melbourne Researchers